This coupled with, growing exploration actions focusing on new biomarkers for detection of breast cancer are many of the major factors driving the breast cancer phase progress. Having said that, the lung cancer section is predicted to grow at a substantial CAGR in the course of the forecast duration of 2019-2026. This can be attributable into the r